Return to home page
Searching: Otterbein library catalog
  Previous Record Previous Item Next Item Next Record
  Reviews, Summaries, etc...
EBOOK
Author Nass, Sharyl J., author.
Title Ensuring patient access to affordable cancer drugs : workshop summary / Sharyl J. Nass and Margie Patlak, rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies.
Imprint Washington, D.C. : The National Academies Press, [2014]

Author Nass, Sharyl J., author.
Subject Cancer -- Treatment -- Costs.
Antineoplastic agents -- Costs.
Drugs -- Costs.
Medical care, Cost of -- United States.
Health services accessibility -- United States.
Neoplasms -- drug therapy.
Prescription Fees.
Health Expenditures.
Antineoplastic Agents -- economics.
Health Services Accessibility -- economics.
United States.
Genre/Form Congresses.
Electronic books.
Alt Name Patlak, Margie, author.
National Cancer Policy Forum (U.S.), organizer, sponsoring body.
Institute of Medicine (U.S.). Board on Health Care Services, issuing body.
Description 1 online resource (1 PDF file (xx, 54 pages)) : illustrations
Note Title from PDF title page.
Bibliography Note Includes bibliographical references.
Summary In recent years, patients' out-of-pocket costs for cancer care have been rising rapidly. These costs include health insurance deductibles, coinsurance, and copayments for covered services, as well as services that are not covered by insurance. Many cancer patients are especially vulnerable financially because their illness and/or treatment impedes their ability to work, with some patients losing employment altogether. Even with insurance, cancer patients often experience financial hardships, such as going into debt, depleting all assets to pay for cancer treatment, and personal bankruptcy. Although many elements contribute to the cost of cancer care, one important component is the cost of new cancer drugs, which has been escalating rapidly in recent years. To explore the issue of cancer drug costs and patient access to affordable, appropriate drug therapies, the Institute of Medicine's National Cancer Policy Forum convened a workshop on ensuring patient access to affordable cancer drugs in June 2014. Affordability was considered from both individual and societal perspectives. The workshop featured discussion panels as well as invited presentations from clinicians, researchers, representatives from the health insurance and pharmaceutical industries, and patient advocates. Ensuring Patient Access to Affordable Cancer Drugs summarizes the presentation and discussion of the workshop.
Note This project was supported by Contract No. HHSN261200900003C between the National Academy of Sciences and the Centers for Disease Control and Prevention and by the American Association for Cancer Research, the American Cancer Society, the American Society for Radiation Oncology, the American Society of Clinical Oncology, the American Society of Hematology, the Association of American Cancer Institutes, C-Change, the CEO Roundtable on Cancer, EMD Serono, Helsinn Healthcare SA, the LIVESTRONG Foundation, the National Comprehensive Cancer Network, Novartis Oncology, the Oncology Nursing Society, and Sanofi Oncology. Additional funding for this workshop was provided by ION Solutions. The views presented in this publication do not necessarily reflect the views of the organizations or agencies that provided support for the activity.
Contents Introduction -- new landscape of caner care -- High out-of-pocket expenses -- Migration of private practices to hospitals -- Factors influencing cancer care access and costs -- Drug shortages -- Reimbursement constraints and incentives -- 340B -- Consolidation of practices -- Potential solutions -- Patient incentives -- Physician incentives --Drug manufacturer incentives -- Wrap-up.
Note Version viewed Apr. 3, 2015.
ISBN 9780309312707
0309312701
9780309312714
030931271X
OCLC # 907514527
Additional Format Print version: Ensuring Patient Access to Cancer Drugs (Workshop) (2014 : Washington, D.C.). Ensuring patient access to afforable cancer drugs. Washington, D.C. : National Academies Press, 2014 9780309312707